Mesothelioma Legal News

Mesothelioma specialist Dr. Dean Fennell has strongly endorsed the use of vinorelbine as a second-line treatment for patients with relapsed disease. He was the lead investigator in a recent phase II clinical trial studying the efficacy of vinorelbine for patients whose pleural mesothelioma cancer had progressed after traditional platinum-based chemotherapy. Fennell, who is chair of […]

The post Clinical Trial Shows Benefits of Vinorelbine for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The novel immunotherapy vaccine ONCOS-102 may become the answer for the large percentage of mesothelioma cancer patients who fail to respond to a recently approved checkpoint inhibitor combination of treatment. ONCOS-102, a genetically modified oncolytic adenovirus, showed an overall survival rate of between 21.9 and 25 months in a randomized phase II clinical trial when […]

The post ONCOS-102 Vaccine Showing Impressive Results for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Researchers in the Netherlands are touting a novel breath test for mesothelioma patients to better predict response to the immunotherapy combination of nivolumab and ipilimumab that was approved recently for first-line treatment of the disease. They believe exhaled breath analysis using electronic technology – known as eNose – can differentiate between responders and nonresponders before […]

The post Breath Test Predicts Immunotherapy Response to Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Under pressure from a multistate coalition, the U.S. Environmental Protection Agency has agreed to tighten its data collection process for asbestos, moving the country another step closer to banning the toxic substance. The agreement comes six months after a U.S. District Court judge in California ruled the EPA must improve its ineffective data collection on […]

The post EPA Agrees to Address Asbestos Data-Collection Deficiencies appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The U.S. Supreme Court rejected a request June 1 from Johnson & Johnson to consider overturning a $2.1 billion award to 22 women who blamed the company’s asbestos-contaminated talcum powder products for causing ovarian cancer. With the Supreme Court declining to consider it, a Missouri state court ruling from 2018 that originally awarded $4.69 billion […]

The post U.S. Supreme Court Rejects J&J Appeal of $2 Billion Talc Verdict appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Memorial Sloan Kettering Cancer Center in New York City will begin recruiting soon for its latest clinical trial involving patients with malignant pleural mesothelioma and the expanded use of immunotherapy. The single-center, phase I study will explore the effectiveness of pembrolizumab in combination with intensity-modulated pleural radiation therapy, known as IMPRINT, in treating unresectable disease. […]

The post Memorial Sloan Kettering Opening New Mesothelioma Clinical Trial appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

A retrospective study involving two decades of pleural mesothelioma patients at the heralded University of Texas MD Anderson Cancer Center failed to demonstrate a definitive survival advantage to support regular use of extrapleural pneumonectomy surgery. The most aggressive surgery possible for this type of mesothelioma – once the surgery of choice – showed no clear […]

The post MD Anderson Examines Aggressive Mesothelioma Surgery in Latest Study appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The Asbestos Disease Awareness Organization delivered on an earlier notice of intent to sue by filing an official complaint against the U.S. Environmental Protection Agency over its ongoing risk evaluation of asbestos. ADAO, a leading nonprofit aimed at preventing asbestos exposure, was joined by five other organizations and several public health experts in asking the […]

The post EPA Facing More Litigation on Legacy Asbestos appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Despite clinical trials that often produce inflated expectations, real-world survival rates for pleural mesothelioma have failed to advance significantly over the past three decades, according to one recent study in Canada. Celebrated treatment advances have fallen short for the average patient diagnosed with this rare cancer caused by exposure to asbestos. “This is a story […]

The post A Look at Three Decades of Real-World Mesothelioma Statistics appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Willie McNeal Jr., a Vietnam War veteran and retired school bus driver, was awarded $4.8 million by a California Superior Court jury that determined asbestos-contaminated talc led to his diagnosis of malignant pleural mesothelioma. Whittaker, Clark & Daniels, a longtime talc supplier now based in South Plainfield, New Jersey, was ordered to pay McNeal $1.8 […]

The post Asbestos-Contaminated Talc Central to Old Spice Mesothelioma Lawsuit appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Canada may soon become the first country to legally restrict the use of popular talc-based products, stemming from an extensive, recently completed human health assessment of the naturally occurring mineral. Health Canada, the governmental agency responsible for national health policy, issued an official advisory in April, concluding that loose talc products – such as body […]

The post Canada Moves Toward Increased Talc Restrictions appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Scientists have discovered that the soil composition typically used by the U.S. Environmental Protection Agency to cap asbestos Superfund sites actually increases mobility of the toxic mineral, sending it into groundwater that could endanger people nearby. This discovery disproves the long-held belief that, once buried, asbestos waste no longer presents a serious problem. The Journal […]

The post Buried Asbestos Remains a Concern at EPA Superfund Sites appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Scientists in Scotland have developed a prototype imaging system using artificial intelligence that has proven effective with malignant mesothelioma, potentially revolutionizing the way patients will be treated in the future. The pilot program could spark much-needed advances in diagnostics and therapeutics. “Mesothelioma is such a complex, incredibly difficult disease,” Dr. Kevin Blythe, professor of respiratory […]

The post Scientists Develop Artificial Intelligence for Mesothelioma Assessment appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Although no amount of asbestos exposure is considered safe, lower levels of non-occupational exposure are most often linked to long-term survival for those diagnosed with malignant pleural mesothelioma, according to a recent study. Clinical Lung Cancer published the study that compared characteristics of 43 pleural mesothelioma patients who survived at least five years with the […]

The post Pleural Mesothelioma Patients with 5-Year Survival Still Rare appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The number of mesothelioma lawsuits filed in 2020 dropped significantly, while cases involving lung cancer continued to increase, according to a recent study reflecting the changing face of asbestos litigation. KCIC, a well-respected consulting firm in Washington, D.C., that manages asbestos product liabilities, released its industry report Thursday. Asbestos legal filings, covering both malignant and […]

The post Latest KCIC Report Finds Decline in Mesothelioma Lawsuits appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.